Live Quote · NASDAQASNDHealthcare· Biotechnology

Ascendis Pharma A/S

$252.73▼ 1.26%($-3.23)
MKT CAP $16.58BNEXT EARNINGS Feb 10, 2027
50%
Bullish
TickerSpark Score
84/100
▌ Strong
50
Valuation
100
Profitability
100
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASND research report →

Analyst Price Target
$310.69+22.9% vs. today

Range $268 – $352

Analyst RatingBuy
24 Buy2 Hold0 Sell

Price Chart

+20.94% · this period
$277.18$236.91$196.63Nov 20May 26Nov 20
52-Week Range69% of range
Low
$188.08
Current
$252.73
High
$282.15

AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice